Allergan Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Allergan (AGN) Tops Q1 EPS by 24c, Offers Q2 and Updated FY Guidance
May 7, 2019 7:03 AM EDTAllergan (NYSE: AGN) reported Q1 EPS of $3.79, $0.24 better than the analyst estimate of $3.55. Revenue for the quarter came in at $3.6 billion versus the consensus estimate of $3.54 billion.
GUIDANCE:
Allergan sees FY2019 EPS of $16.55, versus the consensus of $16.43. Allergan sees FY2019... More



